کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5649506 | 1407126 | 2017 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs
ترجمه فارسی عنوان
انقلاب مولکولی در زیست شناسی پوستی: چشم انداز در حال ظهور در پوست پوستی ژنومی: ایده های مکانیک جدید، ویرایش ژن، و پیشرفت های درمانی
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
NHEJMSCIPSCRDEBalopecia areataCRISPR/Cas9 - CRISPR / Cas9Transcription activator-like effector nuclease - رونویسی مانند actuator nucleaseTALEN - زبان هاMesenchymal stromal cell - سلول استروما MesenchymalInduced pluripotent stem cell - سلول های بنیادی پلوروپتوژن منجر شده استHomologous recombination - نوترکیبی همولوگNonhomologous end-joining - پیوستن به انتهای غیرخطیrecessive dystrophic epidermolysis bullosa - گلودرد اپیدرمولیز دیستروفی خونی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
امراض پوستی
چکیده انگلیسی
Stunning technological advances in genomics have led to spectacular breakthroughs in the understanding of the underlying defects, biological pathways and therapeutic targets of skin diseases leading to new therapeutic interventions. Next-generation sequencing has revolutionized the identification of disease-causing genes and has a profound impact in deciphering gene and protein signatures in rare and frequent skin diseases. Gene addition strategies have shown efficacy in junctional EB and in recessive dystrophic EB (RDEB). TALENs and Cripsr/Cas9 have emerged as highly efficient new tools to edit genomic sequences to creat new models and to correct or disrupt mutated genes to treat human diseases. Therapeutic approaches have not been limited to DNA modification and strategies at the mRNA, protein and cellular levels have also emerged, some of which have already proven clinical efficacy in RDEB. Improved understanding of the pathogenesis of skin disorders has led to the development of specific drugs or repurposing of existing medicines as in basal cell nevus syndrome, alopecia areata, melanoma and EB simplex. These discoveries pave the way for improved targeted personalized medicine for rare and frequent diseases. It is likely that a growing number of orphan skin diseases will benefit from combinatory new therapies in a near future.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Investigative Dermatology - Volume 137, Issue 5, May 2017, Pages e123-e129
Journal: Journal of Investigative Dermatology - Volume 137, Issue 5, May 2017, Pages e123-e129
نویسندگان
Matthias Titeux, Araksya Izmiryan, Alain Hovnanian,